Uncategorized
Global Biotech Perspectives: Takeaways from My Recent Travels to Asia
Thoughts from Geoff Meyerson This past two weeks I had the privilege of visiting Japan and China, hosted by Locust
Episode 29: Asia’s 2025 Q2 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 7:34 — 17.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in
Biotalk Episode 28: 2025 Q2 Report: Global Trends in Biopharma Transactions
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma
Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends
Podcast: Play in new window | Download (Duration: 7:47 — 17.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the
Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO of Locust Walk, shares fresh insights from Japan, China, and Korea,
Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 13:17 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma
Biotalk Episode 24: Asia’s 2024 Year-In-Review
Podcast: Play in new window | Download (Duration: 12:29 — 28.6MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores the evolving biotech landscapes in Japan and China,
Biotalk Episode 23: 2024 Year-In-Review Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Year-In-Review Report: Global Trends in Biopharma
Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offerings
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering PHILADELPHIA and BOSTON, Jan. 7,